Loading…
The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases
Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 ( ) in non-cancerous diseases with a speci...
Saved in:
Published in: | International journal of molecular sciences 2019-02, Vol.20 (3), p.627 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63 |
---|---|
cites | cdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63 |
container_end_page | |
container_issue | 3 |
container_start_page | 627 |
container_title | International journal of molecular sciences |
container_volume | 20 |
creator | Prinz, Felix Kapeller, Anita Pichler, Martin Klec, Christiane |
description | Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 (
) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis,
's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes.
expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate
's capability to be a therapeutic target for non-cancerous diseases. |
doi_str_mv | 10.3390/ijms20030627 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6387324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2332023849</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</originalsourceid><addsrcrecordid>eNpdkc1LAzEUxIMotlZvnmXBiwdXk7w02b0IpdYPLBWknkM2m7Ypu0ndbAX_eyOtpXrKY_LL8CaD0DnBNwA5vrXLOlCMAXMqDlCXMEpTjLk43Js76CSEJcYUaD8_Rh3AggjCsy56mS5M8lyvKqtVa70LiZ8lbdTG3s2TiXfp0Jc2jm-TQTIZDaYksW6jK6dN49chubfBqGDCKTqaqSqYs-3ZQ-8Po-nwKR2_Pj4PB-NUM0LbFJTifc0yWkIGmHBa5FAoJoTql9oUAiAKpcgyljFNGRGlKAvGuMG5xsRw6KG7je9qXdQmvnFtoyq5amytmi_plZV_b5xdyLn_lBwyAZRFg6utQeM_1ia0srZBm6pSzsRAkhKR9xkGTiJ6-Q9d-nXjYjxJAWj80YzlkbreULrxITRmtluGYPnTktxvKeIX-wF28G8t8A1JR4sx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2332023849</pqid></control><display><type>article</type><title>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Prinz, Felix ; Kapeller, Anita ; Pichler, Martin ; Klec, Christiane</creator><creatorcontrib>Prinz, Felix ; Kapeller, Anita ; Pichler, Martin ; Klec, Christiane</creatorcontrib><description>Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 (
) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis,
's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes.
expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate
's capability to be a therapeutic target for non-cancerous diseases.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms20030627</identifier><identifier>PMID: 30717168</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Adenosine ; Breast cancer ; Cancer ; Carcinogenesis ; Carcinogens ; Cytoplasm ; Editing ; Gene expression ; Hepatocellular carcinoma ; Immune response ; Interleukin 8 ; Liver cancer ; Lung cancer ; MicroRNAs ; Neurodegeneration ; Non-coding RNA ; Ovarian cancer ; Physiology ; Prostate ; Prostate cancer ; Proteins ; Retention ; Review ; Stem cells ; Transcription</subject><ispartof>International journal of molecular sciences, 2019-02, Vol.20 (3), p.627</ispartof><rights>2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</citedby><cites>FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</cites><orcidid>0000-0003-0195-8280 ; 0000-0002-8701-9462</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2332023849/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2332023849?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30717168$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prinz, Felix</creatorcontrib><creatorcontrib>Kapeller, Anita</creatorcontrib><creatorcontrib>Pichler, Martin</creatorcontrib><creatorcontrib>Klec, Christiane</creatorcontrib><title>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 (
) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis,
's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes.
expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate
's capability to be a therapeutic target for non-cancerous diseases.</description><subject>Adenosine</subject><subject>Breast cancer</subject><subject>Cancer</subject><subject>Carcinogenesis</subject><subject>Carcinogens</subject><subject>Cytoplasm</subject><subject>Editing</subject><subject>Gene expression</subject><subject>Hepatocellular carcinoma</subject><subject>Immune response</subject><subject>Interleukin 8</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>MicroRNAs</subject><subject>Neurodegeneration</subject><subject>Non-coding RNA</subject><subject>Ovarian cancer</subject><subject>Physiology</subject><subject>Prostate</subject><subject>Prostate cancer</subject><subject>Proteins</subject><subject>Retention</subject><subject>Review</subject><subject>Stem cells</subject><subject>Transcription</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1LAzEUxIMotlZvnmXBiwdXk7w02b0IpdYPLBWknkM2m7Ypu0ndbAX_eyOtpXrKY_LL8CaD0DnBNwA5vrXLOlCMAXMqDlCXMEpTjLk43Js76CSEJcYUaD8_Rh3AggjCsy56mS5M8lyvKqtVa70LiZ8lbdTG3s2TiXfp0Jc2jm-TQTIZDaYksW6jK6dN49chubfBqGDCKTqaqSqYs-3ZQ-8Po-nwKR2_Pj4PB-NUM0LbFJTifc0yWkIGmHBa5FAoJoTql9oUAiAKpcgyljFNGRGlKAvGuMG5xsRw6KG7je9qXdQmvnFtoyq5amytmi_plZV_b5xdyLn_lBwyAZRFg6utQeM_1ia0srZBm6pSzsRAkhKR9xkGTiJ6-Q9d-nXjYjxJAWj80YzlkbreULrxITRmtluGYPnTktxvKeIX-wF28G8t8A1JR4sx</recordid><startdate>20190201</startdate><enddate>20190201</enddate><creator>Prinz, Felix</creator><creator>Kapeller, Anita</creator><creator>Pichler, Martin</creator><creator>Klec, Christiane</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0195-8280</orcidid><orcidid>https://orcid.org/0000-0002-8701-9462</orcidid></search><sort><creationdate>20190201</creationdate><title>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</title><author>Prinz, Felix ; Kapeller, Anita ; Pichler, Martin ; Klec, Christiane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adenosine</topic><topic>Breast cancer</topic><topic>Cancer</topic><topic>Carcinogenesis</topic><topic>Carcinogens</topic><topic>Cytoplasm</topic><topic>Editing</topic><topic>Gene expression</topic><topic>Hepatocellular carcinoma</topic><topic>Immune response</topic><topic>Interleukin 8</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>MicroRNAs</topic><topic>Neurodegeneration</topic><topic>Non-coding RNA</topic><topic>Ovarian cancer</topic><topic>Physiology</topic><topic>Prostate</topic><topic>Prostate cancer</topic><topic>Proteins</topic><topic>Retention</topic><topic>Review</topic><topic>Stem cells</topic><topic>Transcription</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prinz, Felix</creatorcontrib><creatorcontrib>Kapeller, Anita</creatorcontrib><creatorcontrib>Pichler, Martin</creatorcontrib><creatorcontrib>Klec, Christiane</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prinz, Felix</au><au>Kapeller, Anita</au><au>Pichler, Martin</au><au>Klec, Christiane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2019-02-01</date><risdate>2019</risdate><volume>20</volume><issue>3</issue><spage>627</spage><pages>627-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Long non-coding RNAs (lncRNAs) are involved in a variety of biological and cellular processes as well as in physiologic and pathophysiologic events. This review summarizes recent literature about the role of the lncRNA nuclear enriched abundant transcript 1 (
) in non-cancerous diseases with a special focus on viral infections and neurodegenerative diseases. In contrast to its role as competing endogenous RNA (ceRNA) in carcinogenesis,
's function in non-cancerous diseases predominantly focuses on paraspeckle-mediated effects on gene expression. This involves processes such as nuclear retention of mRNAs or sequestration of paraspeckle proteins from specific promoters, resulting in transcriptional induction or repression of genes involved in regulating the immune system or neurodegenerative processes.
expression is aberrantly-mostly upregulated-in non-cancerous pathological conditions, indicating that it could serve as potential prognostic biomarker. Additional studies are needed to elucidate
's capability to be a therapeutic target for non-cancerous diseases.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>30717168</pmid><doi>10.3390/ijms20030627</doi><orcidid>https://orcid.org/0000-0003-0195-8280</orcidid><orcidid>https://orcid.org/0000-0002-8701-9462</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2019-02, Vol.20 (3), p.627 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6387324 |
source | PMC (PubMed Central); Publicly Available Content (ProQuest) |
subjects | Adenosine Breast cancer Cancer Carcinogenesis Carcinogens Cytoplasm Editing Gene expression Hepatocellular carcinoma Immune response Interleukin 8 Liver cancer Lung cancer MicroRNAs Neurodegeneration Non-coding RNA Ovarian cancer Physiology Prostate Prostate cancer Proteins Retention Review Stem cells Transcription |
title | The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-05T21%3A42%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Implications%20of%20the%20Long%20Non-Coding%20RNA%20NEAT1%20in%20Non-Cancerous%20Diseases&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Prinz,%20Felix&rft.date=2019-02-01&rft.volume=20&rft.issue=3&rft.spage=627&rft.pages=627-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms20030627&rft_dat=%3Cproquest_pubme%3E2332023849%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-3aa65c482d3830162b93ba477a5dceb733b93d788484c2417d7db446e09c01e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2332023849&rft_id=info:pmid/30717168&rfr_iscdi=true |